Argent Capital Management LLC Purchases 1,947 Shares of Addus HomeCare Co. (NASDAQ:ADUS)

Argent Capital Management LLC grew its holdings in Addus HomeCare Co. (NASDAQ:ADUS) by 5.2% during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 39,257 shares of the company’s stock after acquiring an additional 1,947 shares during the period. Argent Capital Management LLC owned about 0.22% of Addus HomeCare worth $5,222,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Texas Permanent School Fund Corp boosted its stake in Addus HomeCare by 0.6% during the second quarter. Texas Permanent School Fund Corp now owns 14,089 shares of the company’s stock valued at $1,636,000 after buying an additional 82 shares during the last quarter. Arizona State Retirement System lifted its position in Addus HomeCare by 2.0% during the second quarter. Arizona State Retirement System now owns 4,543 shares of the company’s stock valued at $527,000 after purchasing an additional 87 shares during the last quarter. UMB Bank n.a. lifted its position in Addus HomeCare by 64.2% during the second quarter. UMB Bank n.a. now owns 225 shares of the company’s stock valued at $26,000 after purchasing an additional 88 shares during the last quarter. Inspire Investing LLC grew its stake in shares of Addus HomeCare by 3.3% in the 3rd quarter. Inspire Investing LLC now owns 3,111 shares of the company’s stock worth $414,000 after buying an additional 100 shares in the last quarter. Finally, Azzad Asset Management Inc. ADV increased its holdings in shares of Addus HomeCare by 1.3% in the 2nd quarter. Azzad Asset Management Inc. ADV now owns 8,436 shares of the company’s stock worth $980,000 after buying an additional 110 shares during the last quarter. Institutional investors own 95.35% of the company’s stock.

Analyst Ratings Changes

ADUS has been the subject of a number of analyst reports. TD Cowen increased their price target on shares of Addus HomeCare from $128.00 to $137.00 and gave the company a “buy” rating in a report on Thursday, August 8th. StockNews.com downgraded Addus HomeCare from a “strong-buy” rating to a “buy” rating in a research report on Sunday, July 7th. Macquarie restated an “outperform” rating and issued a $139.00 price target on shares of Addus HomeCare in a research report on Friday, October 11th. Oppenheimer boosted their price objective on shares of Addus HomeCare from $140.00 to $145.00 and gave the company an “outperform” rating in a research report on Monday, September 23rd. Finally, KeyCorp initiated coverage on shares of Addus HomeCare in a research report on Friday, October 11th. They issued an “overweight” rating and a $150.00 price objective on the stock. One analyst has rated the stock with a sell rating, eight have issued a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat, Addus HomeCare currently has a consensus rating of “Moderate Buy” and a consensus target price of $131.38.

Addus HomeCare Stock Down 0.1 %

Shares of NASDAQ ADUS traded down $0.19 during midday trading on Thursday, reaching $129.20. 18,953 shares of the company’s stock traded hands, compared to its average volume of 130,389. The stock’s 50 day simple moving average is $130.64 and its 200-day simple moving average is $118.84. The company has a market cap of $2.34 billion, a price-to-earnings ratio of 32.11, a P/E/G ratio of 2.33 and a beta of 1.04. Addus HomeCare Co. has a one year low of $78.35 and a one year high of $136.12.

Addus HomeCare (NASDAQ:ADUS) last announced its quarterly earnings data on Monday, August 5th. The company reported $1.35 EPS for the quarter, beating the consensus estimate of $1.21 by $0.14. Addus HomeCare had a net margin of 6.18% and a return on equity of 9.81%. The firm had revenue of $286.90 million during the quarter, compared to analyst estimates of $284.90 million. During the same period last year, the firm posted $0.94 EPS. Addus HomeCare’s revenue was up 10.4% on a year-over-year basis. Equities analysts predict that Addus HomeCare Co. will post 4.58 EPS for the current fiscal year.

Insider Activity at Addus HomeCare

In other Addus HomeCare news, EVP Michael D. Wattenbarger sold 21,917 shares of the company’s stock in a transaction on Monday, August 26th. The shares were sold at an average price of $133.29, for a total transaction of $2,921,316.93. Following the completion of the transaction, the executive vice president now directly owns 7,215 shares in the company, valued at approximately $961,687.35. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In other news, EVP Michael D. Wattenbarger sold 21,917 shares of Addus HomeCare stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $133.29, for a total value of $2,921,316.93. Following the sale, the executive vice president now directly owns 7,215 shares of the company’s stock, valued at $961,687.35. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Esteban Lopez sold 500 shares of the firm’s stock in a transaction on Tuesday, September 10th. The shares were sold at an average price of $127.50, for a total value of $63,750.00. Following the completion of the transaction, the director now owns 3,366 shares in the company, valued at $429,165. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 22,917 shares of company stock worth $3,050,082 in the last three months. Company insiders own 4.60% of the company’s stock.

Addus HomeCare Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.